Author Weber, Martin S.

• 2012 | Journal Article | 
  ​ ​IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis​
  Benkhoucha, M.; Molnarfi, N.; Santiago-Raber, M.-L.; Weber, M. S.; Merkler, D.; Collin, M. & Lalive, P. H.​ (2012) 
  Journal of Neuroinflammation, 9 art. 209​.​ DOI: https://doi.org/10.1186/1742-2094-9-209 
  ​Details  DOI  PMID  PMC  WoS 

• 2012 | Journal Article | 
  ​ ​Favourable response to plasma exchange in tumefactive CNS demyelination with delayed B-cell response​
  Seifert, C. L.; Wegner, C.; Sprenger, T.; Weber, M. S.; Brueck, W.; Hemmer, B. & Sellner, J.​ (2012) 
  Multiple Sclerosis Journal, 18(7) pp. 1045​-1049​.​ DOI: https://doi.org/10.1177/1352458511429012 
  ​Details  DOI  PMID  PMC  WoS 

• 2013 | Review
  ​ ​Therapeutic Decisions in Multiple Sclerosis Moving Beyond Efficacy​
  Brueck, W.; Gold, R.; Lund, B. T.; Oreja-Guevara, C.; Prat, A.; Spencer, C. M.& Steinman, L. et al.​ (2013)
  JAMA Neurology, 70​(10) pp. 1315​-1324​.​
  Amer Medical Assoc. DOI: https://doi.org/10.1001/jamaneurol.2013.3510 
  ​Details  DOI  PMID  PMC  WoS 

• 2013 | Journal Article
  ​ ​Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity​
  Hertzenberg, D.; Lehmann-Horn, K.; Kinzel, S.; Husterer, V.; Cravens, P. D.; Kieseier, B. C. & Hemmer, B. et al.​ (2013) 
  European Journal of Immunology, 43(8) pp. 2078​-2088​.​ DOI: https://doi.org/10.1002/eji.201343338 
  ​Details  DOI  PMID  PMC  WoS 

• 2013 | Journal Article | 
  ​ ​The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis​
  Cravens, P. D.; Kieseier, B. C.; Hussain, R. Z.; Herndon, E.; Arellano, B.; Ben, L.-H. & Timmons, B. C. et al.​ (2013) 
  Journal of Neuroinflammation, 10 art. 67​.​ DOI: https://doi.org/10.1186/1742-2094-10-67 
  ​Details  DOI  PMID  PMC  WoS 

• 2013 | Review
  ​ ​Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges​
  Lehmann-Horn, K.; Kronsbein, H. C.& Weber, M. S.​ (2013)
  Therapeutic Advances in Neurological Disorders, 6​(3) pp. 161​-173​.​
  Sage Publications Ltd. DOI: https://doi.org/10.1177/1756285612474333 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Conference Abstract
  ​ ​Myelin-specific antibodies trigger spontaneous CNS autoimmune disease in the absence of myelin-specific B cells​
  Kinzel, S.; Lehmann-Horn, K.; Zamvil, S. S.; Winkler, A. ; Bernard, C. C.; Stadelmann-Nessler, C.   & Brueck, W. et al.​ (2014)
  Journal of Neuroimmunology, 275(1-2) pp. 7​-8. , Mainz, GERMANY.
  Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/j.jneuroim.2014.08.026 
  ​Details  DOI  WoS 

• 2014 | Conference Abstract
  ​ ​Following anti-CD20 treatment, compartment-specific repletion with immune-competent B cells depends on activation of reappearing B cells​
  Feldmann, L. & Weber, M. S.​ (2014)
  Journal of Neuroimmunology, 275(1-2) ​12th International Congress of Neuroimmunology (ISNI)​, Mainz, GERMANY.
  Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/j.jneuroim.2014.08.052 
  ​Details  DOI  WoS 

• 2014 | Journal Article | 
  ​ ​Neither T-helper type 2 nor Foxp3(+) regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity​
  Weber, M. S.; Prod'homme, T.; Youssef, S.; Dunn, S. E.; Steinman, L. & Zamvil, S. S.​ (2014) 
  Journal of Neuroinflammation, 11 art. 29​.​ DOI: https://doi.org/10.1186/1742-2094-11-29 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Journal Article
  ​ ​Immunopathogenesis of Neuromyelitis Optica​
  Levy, M.; Wildemann, B.; Jarius, S.; Orellano, B.; Sasidharan, S.; Weber, M. S. & Stuve, O.​ (2014) 
  Advances in Immunology, 121 pp. 213​-242​.​ DOI: https://doi.org/10.1016/B978-0-12-800100-4.00006-4 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Journal Article | 
  ​ ​Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity​
  Lehmann-Horn, K.; Kinzel, S.; Feldmann, L.; Radelfahr, F.; Hemmer, B.; Traffehn, S. & Bernard, C. C. A. et al.​ (2014) 
  Annals of Clinical and Translational Neurology, 1(7) pp. 490​-496​.​ DOI: https://doi.org/10.1002/acn3.71 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Journal Article | 
  ​ ​Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE.​
  Shetty, A.; Gupta, S. G.; Varrin-Doyer, M.; Weber, M. S.; Prod'homme, T.; Molnarfi, N. & Ji, N. et al.​ (2014) 
  Neurology® neuroimmunology & neuroinflammation, 1(2) art. e22​.​ DOI: https://doi.org/10.1212/NXI.0000000000000022 
  ​Details  DOI  PMID  PMC 

• 2014 | Journal Article | 
  ​ ​MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.​
  Varrin-Doyer, M.; Shetty, A.; Spencer, C. M.; Schulze-Topphoff, U.; Weber, M. S.; Bernard, C. C. A. & Forsthuber, T. et al.​ (2014) 
  Neurology® neuroimmunology & neuroinflammation, 1(2) art. e20​.​ DOI: https://doi.org/10.1212/NXI.0000000000000020 
  ​Details  DOI  PMID  PMC 

• 2015 | Journal Article | Letter Note
  ​ ​Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis Is Intrathecal Anti-CD20 a Therapeutic Option?​
  Fereidan-Esfahani, M. ; Brueck, W. & Weber, M. S.​ (2015) 
  JAMA Neurology, 72(12) pp. 1407​-1408​.​ DOI: https://doi.org/10.1001/jamaneurol.2015.2869 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​Tyrphostin AG126 Exerts Neuroprotection in CNS Inflammation by a Dual Mechanism​
  Menzfeld, C.; John, M.; van Rossum, D.; Regen, T.; Scheffel, J.; Janova, H.   & Goetz, A. A. et al.​ (2015) 
  Glia, 63(6) pp. 1083​-1099​.​ DOI: https://doi.org/10.1002/glia.22803 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article | 
  ​ ​Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?​
  Weber, M. S.​ (2015) 
  Neurology® neuroimmunology & neuroinflammation, 2(2) art. e84​.​ DOI: https://doi.org/10.1212/NXI.0000000000000084 
  ​Details  DOI  PMID  PMC 

• 2015 | Journal Article | 
  ​ ​Glial cells express nuclear nrf2 after fumarate treatment for multiple sclerosis and psoriasis.​
  Metz, I.; Traffehn, S.; Straßburger-Krogias, K.; Keyvani, K.; Bergmann, M.; Nolte, K. & Weber, M. S. et al.​ (2015) 
  Neurology® neuroimmunology & neuroinflammation, 2(3) art. e99​.​ DOI: https://doi.org/10.1212/NXI.0000000000000099 
  ​Details  DOI  PMID  PMC 

• 2015 | Journal Article | 
  ​ ​Glatiramer acetate treatment negatively regulates type I interferon signaling.​
  Molnarfi, N.; Prod'homme, T.; Schulze-Topphoff, U.; Spencer, C. M.; Weber, M. S.; Patarroyo, J. C. & Lalive, P. H. et al.​ (2015) 
  Neurology® neuroimmunology & neuroinflammation, 2(6) art. e179​.​ DOI: https://doi.org/10.1212/NXI.0000000000000179 
  ​Details  DOI  PMID  PMC 

• 2016 | Journal Article | 
  ​ ​B cell-derived transforming growth factor-beta 1 expression limits the induction phase of autoimmune neuroinflammation​
  Bjarnadottir, K.; Benkhoucha, M.; Merkler, D.; Weber, M. S.; Payne, N. L.; Bernard, C. C. A. & Molnarfi, N. et al.​ (2016) 
  Scientific Reports, 6 art. 34594​.​ DOI: https://doi.org/10.1038/srep34594 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Review
  ​ ​The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis​
  Kretzschmar, B.; Pellkofer, H. L.& Weber, M. S.​ (2016)
  Current Neurology and Neuroscience Reports, 16​(4).​
  Springer. DOI: https://doi.org/10.1007/s11910-016-0639-4 
  ​Details  DOI  PMID  PMC  WoS 

Researcher

Sort

Items per Page